Mon 16 Nov 2009 | 23:13 EST

You are here: Home > News > Article

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Crucell announces STAR(TM) Research license agreement

Tue Jan 30, 2007 11:49pm EST

Email | Print |

Share

| Reprints | Single Page

[-] Text [+]

Co announces that it has signed a non-exclusive STAR(TM) research license agreement for the production of monoclonal antibodies with Abbott (ABT). Under the agreement, Abbott would evaluate Crucell's STAR(TM) technology for generating cell lines for manufacture of biopharmaceuticals. Financial details were not disclosed.

© Thomson Reuters 2009 All rights reserved

Share:

Also On Reuters

Workers install a pink ribbon in to promote awareness of breast cancer on the front of the White House in Washington, October 26, 2009. REUTERS/Jonathan Ernst

Sweeping new breast cancer guidelines controversial

The Vulcan statue is seen at Vulcan Park in Birmingham, Alabama November 14, 2009. The Vulcan statue is a symbol of old times at the iron industry in Birmingham. REUTERS/Carlos Barria

Blog: Toyota plant workers sheltered from the downturn

Charles Darwin in an undated photo. REUTERS/File

Blog: Muslim creationism is back in the news

More InPlay Briefing.com

Insight Enterprises' board authorizes additional $50 mln stock repurchase

Ampex and Hillside agree to 60 day extension to standstillaAgreement; engages Commercial Strategy to pursue licensing efforts

New Oriental reports Q2 EPS of $0.07 vs $0.10 in 2Q07; revs rose 129% to $18.2 mln - no ests

General Steel reports Q3 EPS of $0.25 vs $0.20 two analyst est; revs rose $636% YoY to $345.4 mln vs $289.86 mln two analyst est

Ansoft beats by $0.01, reports revs in-line

More InPlay Briefing.com News...

Featured Broker sponsored link

Editor's Choice

A diver dressed as Santa Claus swims with dolphins at Hakkeijima Sea Paradise in Yokohama

A selection of our best photos from the past 24 hours. Slideshow

Most Popular on Reuters

Articles
Video

Most Popular Articles RSS Feed

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.